Pictet North America Advisors’s Edwards Lifesciences EW Stock Holding History

Pictet North America Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,703	Closed	-$443K	–	146
2019 Q4	$443K	Hold	5,703	–	–	0.05%	120
2019 Q3	$418K	Hold	5,703	–	–	0.06%	119
2019 Q2	$351K	Hold	5,703	–	–	0.05%	125
2019 Q1	$364K	Sell	5,703 -1,020	-15%	-$58.2K	0.05%	128
2018 Q4	$343K	Hold	6,723	–	–	0.03%	134
2018 Q3	$390K	Sell	6,723 -900	-12%	-$44K	0.05%	138
2018 Q2	$370K	Hold	7,623	–	–	0.06%	112
2018 Q1	$355K	Buy	+7,623	New	+$331K	0.05%	108
2017 Q2	–	Sell	-14,400	Closed	-$452K	–	134
2017 Q1	$452K	Buy	+14,400	New	+$451K	0.08%	89

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Pictet North America Advisors's EW Position: Q1 2020 in Review

Pictet North America Advisors sold out of Edwards Lifesciences (EW) in Q1 2020, closing a stake of 5,703 shares — an estimated $443K sold.

Pictet North America Advisors first reported a position in EW in Q1 2017 and held it in 9 quarters. The position peaked at $452K in Q1 2017. 1,019 funds tracked by Wall St. Rank hold EW as of Q1 2020.

Pictet North America Advisors reported no remaining Edwards Lifesciences position as of Q1 2020 after selling out during the quarter.
Pictet North America Advisors sold 5,703 Edwards Lifesciences shares in Q1 2020, an estimated $443K.
Pictet North America Advisors first reported a position in Edwards Lifesciences in Q1 2017 and held it in 9 quarters.
Pictet North America Advisors's Edwards Lifesciences position peaked at $452K in Q1 2017.
1,019 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2020.

Based on Pictet North America Advisors's 13F filing for Q1 2020, filed 30 Apr 2020.